Garvan's mission is to make significant contributions to medical research that will change the directions of science and medicine and have major impacts on human health. Garvan strives to enhance and develop research programs that combine fundamental science with strong clinical interactions.
Pharmacogenomics: DNA tests to inform drug selection and dosage decisions
Despite making significant progress over the last two decades, implementation of pharmacogenomic testing into routine clinical practice is currently limited. Read on to find out more about these tests, their uses, and how they can help to inform drug selection and dosage decisions.
DNA Days are here: navigating genomic tests in primary care
GPs are trusted sources of information about genome sequencing and are the profession most likely to be approached by people with results from online and consumer DNA tests. Read on to learn more about the important role GPs can play when it comes to navigating genomic tests in primary care.
Navigating genomic testing in primary care
This module seeks to educate GPs and others working in the primary care space about how genomic testing can improve patient outcomes, the appropriate referral pathways, issues surrounding notifying family when genomic testing reveals a hereditary condition, and legal matters such as privacy and impact on insurance.
